The Scientist

» ecology and disease/medicine

Most Recent

image: Hearts on Trial

Hearts on Trial

By | May 1, 2015

As researchers conduct the most rigorous human trials of cardiac cell therapies yet attempted, a clear picture of whether these treatments actually work is imminent.


image: Bees Drawn to Pesticides

Bees Drawn to Pesticides

By | April 24, 2015

One study shows the insects prefer food laced with pesticides, while another adds to the evidence that the chemicals are harmful to some pollinators.


image: FDA Calls for Data on ALS Drug

FDA Calls for Data on ALS Drug

By | April 21, 2015

In the midst of a debate about an experimental drug’s early approval, the US Food and Drug Administration requests that full trial results be released.

1 Comment

image: Protein Spurs T-Cell Proliferation

Protein Spurs T-Cell Proliferation

By | April 17, 2015

A newly discovered protein promotes immunity to viruses and cancer by triggering the production of cytotoxic T cells.

1 Comment

image: Cancer Sequencing Controls

Cancer Sequencing Controls

By | April 15, 2015

Comparing a patient’s tumor DNA sequence with that of her normal tissue can improve researchers’ identification of disease-associated mutations.

1 Comment

image: Cannabidiol Quells Seizures

Cannabidiol Quells Seizures

By | April 14, 2015

The marijuana-derived compound shows promise in treating rare forms of epilepsy that cause children to have seizures multiple times a day.


image: Why DBS Works for Parkinson’s?

Why DBS Works for Parkinson’s?

By | April 14, 2015

Deep-brain stimulation may effectively treat slow movement, tremor, and rigidity in Parkinson’s patients by reducing synchronicity of neural activity in the motor cortex.


image: Ebola Vaccines Protect Monkeys

Ebola Vaccines Protect Monkeys

By | April 9, 2015

Two new Ebola vaccine candidates prove safe and effective against the virus in macaques, a study shows.


image: HIV Antibody Therapy

HIV Antibody Therapy

By | April 8, 2015

Delivering antibodies to HIV-infected people can lower levels of the virus, a study shows.


image: ALS Drug Access Debated

ALS Drug Access Debated

By | April 7, 2015

Biotech company Genervon has requested accelerated approval for its experimental ALS drug after a small but promising Phase 2 trial. Patients advocate for its acceptance, while researchers urge caution.


Popular Now

  1. Antidepressant Exerts Epigenetic Changes
  2. Inside a Lab Mouse’s High-Fat Diet
  3. Image of the Day: Mother’s Love
  4. Remote Mind Control
Life Technologies